AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.

Psychedelic therapies are emerging as promising treatments for various mental health conditions, such as depression, post-traumatic stress disorder (PTSD), anxiety and substance-use disorders.

Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

Identified as “Mr. A,” the man experienced “suffering and functional decline” following three vaccinations for SARS-CoV-2. He also suffered from depression, post-traumatic stress disorder, anxiety and ...

I do not want our work to be weaponized,” said Johanna Olson-Kennedy, a doctor involved in the study. “It has to be exactly ...

According to the results of a new study conducted by researchers from the National University Arturo Jauretche in Argentina, ...

A prescription digital therapeutic for insomnia was associated with significant improvements in sleep, depression, and anxiety.

The leader of the long-running study said that the drugs did not improve mental health in children with gender distress and ...

The stigma surrounding professional treatment amplifies mental health disorders in India.

A Waterloo clinic is treating post-traumatic stress disorder (PTSD) and anxiety with ketamine treatments, a drug ...

Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant ...

Although children today are being raised in a more diverse and inclusive world, shame still continues to negatively affect ...